Effect of nitroprusside on arteriolar constriction after retinal branch vein occlusion

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 10, 1998, Pages 1910-1917

  Donati, Guy ^a   Poimiaras, Constantin ^a,b   Tsacoponlos, Marco ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Experimental Ophthalmology Laboratory   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; INTRAOCULAR DRUG ADMINISTRATION; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA VEIN OCCLUSION; SWINE;

ANIMALS; ARGININE; CONSTRICTION, PATHOLOGIC; NITRIC OXIDE; NITROPRUSSIDE; REGIONAL BLOOD FLOW; RETINAL ARTERY; RETINAL VEIN OCCLUSION; SWINE; SWINE, MINIATURE; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 0031708612     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Wise GN. Arteriosclerosis secondary to retinal vein obstruction. Trans Am Opbtbalmol Soc. 1958;56:36l-382.
2. Wise G, Dollery C, Henkind P. Tljc Retinal Circulation. New York: Harper & Row; 1971:213,294,352-355.
3. Coscas G, Dhermy P. Occlusions Veineuses Rétiniennes. Paris: Masson. 1978:57-76, 157-259, 245-246.
4. Kohner EM, Shilling JS, Clemett RS. Clinical aspects of retinal branch vein occlusion significant for the understanding of its pathogenesis and preventive therapy. Doc Opbtbalmol Proc. 1974;5:153-l60.
5. Kohner EM, Dollery CT, Shakib M, et al. Experimental retinal branch vein occlusion. Am J Ophtbalmol. 1970;69:778-825.
6. Frangieh G, Green WR, Barraquer E, Finkelstein D. Hystopathologic study of nine branch venous occlusions. Arch Ophtbalmol. 1982;100:1132-1140.
7. Donati G, Pournaras CJ, Munoz JL, Poitr)f-Yamate C, Tsacopouls M. Nitric oxide controls aneriolar tone in the retina of the miniature pig. Invest Opbtbalinol Vis Sci. 199536:11:2228-2237.
8. Donati G, Pournaras CJ, Pizzolato GP, Tsacopoulos M. Decreased nitric oxide production accounts for secondary arteriolar constriction after retinal branch vein occlusion. Invest Opbtbalinol Vis Sci. 199738:1450-1456.
9. 2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res. 1989:49:347-360.
10. Pournaras CJ, Shonat JL, Munoz J-L, Petrig BL. New ocular micromanipulator for measurements of retinal and vitreous physiologic parameters in the mammalian eye. Exp Eye Res. 1991;53:723-727.
11. Newson RSB, Sullivan PM, Rassam S.MB, Jagoe R, Kohner E. Retinal vessel measurement: comparison between observer and computer driven methods. Graefes Arch Clin Exp Opbtbalinol. 1992;230: 221-225.
12. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM. Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology. 1990;97:1321-1328.
13. Coscas G, Sterkers M. Occlusion expérimentale de branches veineuses rétiniennes par photocoagulation au laser a argon chez le singe. Ann Oculist. 1977;210:919-936.
14. Brazitikos PD, Poumaras CJ, Munoz J-L, Tsacopoulos M. Microinjection of L-lactate in the preretinal vitreous induces segmentai vasodilatation in the inner retina of miniature pigs. Invest Opbthalmol Vis Sci. 1993;34:1745-1752.
15. Meyer P, Flammer J, Lüscher TF. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest Ophthcilmol Vis Sci. 1993:34:3614-3621.
16. Haefliger I, Meyer P, Flammer J, Lüscher T. The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology-. Surv Opbtbalmol. 1994;39:2:123-132.
17. Becquet F, Courtois Y, Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv Opbtbalinol. 1997;42: 71-82.
18. Dalkara T, Moskowitz MA. The complex role of nitric oxide in the pathophysiology of focal cerebral ischemia. 1994;4:49-57.
19. Dawson DA. Nitric oxide and focal ischemia: multiplicity of actions and diverse outcome. Cerebrovasc Rrain Metab Rev. 1994; 6:229-324.
20. Ophir A, Berenshtein E, Kitrossky N, et al. Hydroxyl radical generation in the cat retina during reperfusion following ischemia. Exp Eye Res. 1993:57:351-357.
21. Gehlbach P, Purple RL. Enhancement of retinal recover)- by conjugated deferoxamine after ischemia reperfusion. Invest Opbtbalmol Vis Sci. 1994:35:669-676.
22. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994:78:931-936.
23. Geyer O, Almog J, Lupu-Meiri M, Lazar M, Oron Y. Nitric oxide synthase inhibitors protect rat retina against ischémie injury. FEES Lett. 1995:374:399-402.
24. Archer DB, Ernest JT, Maguire CJF. Experimental branch vein obstruction. In: Cant JS, ed. Vision and Circulation. London: Kimpton H; 1976:226-242.
25. Rosen DA, Marshall J, Kohner EM, Hamilton AM, Doller)' CT. Experimental retinal branch vein occlusion in the rhesus monkey, II: Retinal blood flow studies. BrJ Opblbalmol. 1979;1:63:388-392.
26. Pournaras CJ. Retinal oxygen distribution. Its role in the physiopathology of vasoproliferative microangiopathies. Retina. 1995; 15:4:332-347.
27. Huxlin KR, Bennett MR. NADPH diaphorase expression in the rat retina after axotomy: a supportive role for nitric oxide. EnrJ Neurosci. 1995;7:2226-2239.
28. Ostwald P, Goldstein IR, Pachnanda A, Roth S. Effect of nitric oxydes synthase inhibition on blood flow after retinal ischemia in cats. Im-est Opbtbalmol Vis Set. 1995;36:2396-2403.
29. Seligsohn EE, Bill A. Effects of A-nitro-L-arginine methyl ester on the cardiovascular system of the anaesthetized rabbit and on the cardiovascular response to thyrotropin-releasing hormone. BrJ Pbartnacol. 1993;109:1219-1225.
30. Toda N, Kitamura Y, Okamura T. Role of nitroxidergic nerve in dog retinal arterioles in vivo and arteries in vitro. Am J Pbysiol. 1994;226:1985-1992.
31. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989;65:1-21.
32. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pbannacol Toxicol. 1990;30:535-560.
33. Moncada S. Nitric oxide: physiolog)1, pathophysiology and pharmacology. Pbannacol Rev. 1991;43:109-142.
34. Knowles RG, Moncada S. Nitric oxide synthase in mammals. Biocbcmj. 1994;198:249-258.
35. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biocbem. 1994;63:175-I95.
36. Brien JF, Mclauchlin BE, Nakatsu K, Marks GS. Quantitation of nitric oxide formation from nitrovasodilator dnigs by chemiluminescence analysis of headspace gas. J Pbannacol Methods. 1991; 25:19-27.
37. Bates JN, Baker MT, Guerra R, Harrison D. Nitric oxide generation from nitroprusside by vascular tissue. Biocbem Pharmacol. 1991; 42(suppl):157-l65.
38. Michenfelder JD, Tinker JH. Cyanide toxicity and thiosulfate protection during chronic administration of sodium nitroprusside in the dog: correlation with a human case. Ancslbesiolog)'. 1977;47: 441-448.
39. StamlerJS, Jia L, EuJP, et'al. Blood flow regulation by 5-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276: 2034-2037.
40. Pohl U, Busse R. Hypoxia stimulates release of endotheliumderived relaxant factor. Am J Pbysiol. 1989;25:256:H1595H1600.
41. Carville C, Raffestin B, Eddahibi S, Blouquit Y, Adnot S. Loss of endothelium-dependent relaxation in proximal pulmonary arteries from rats exposed to chronic hypoxia: effects of in vivo and in vitro supplementation with L-arginine. J Cardiovasc Pbannacol. 1992;22:889-896.
42. Bogle R, Moncada S, Pearson JD, Mann G. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. BrJ Pbannacol. 1992;105:768-770.